FTO and acute myeloid leukemia: Overall, our findings do not support an ‘m6A eraser’ role for FTO in AML cell lines under the conditions tested, and they suggest that the reported demethylation functions of FTO on m6A should be reinvestigated using quantitative m6A mapping methods.